A Study to Compare How CHF10196 (Florensocatib) is Absorbed Into the Blood When Given Alone and With a Drug That Reduces Stomach Acid in Healthy Male Participants

This Phase 1 study evaluates the effect of pantoprazole (a proton pump inhibitor) on the pharmacokinetics (PK) of CHF10196 (Florensocatib) in healthy male participants. Participants receive CHF10196 alone and in combination with pantoprazole to assess potential drug-drug interaction (DDI) effects on systemic exposure.

NCT Number	NCT07683793
Lead Sponsor	Chiesi Farmaceutici S.p.A.
Conditions	Healthy Volunteers
Enrollment	18 participants
Start Date	2026-10-14
Primary Completion	2026-12-09 (estimated)
Study Completion	2026-12-09 (estimated)
Updated on ClinicalTrials.gov	2026-07-06